193 related articles for article (PubMed ID: 8420178)
1. Positron emission tomography in hemiparkinsonism-hemiatrophy syndrome.
Przedborski S; Goldman S; Giladi N; Dhawan V; Takikawa S; Hildebrand J; Fahn S; Eidelberg D
Adv Neurol; 1993; 60():501-5. PubMed ID: 8420178
[No Abstract] [Full Text] [Related]
2. Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia, and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.
Lang AE
Mov Disord; 1995 Jul; 10(4):489-95. PubMed ID: 7565831
[TBL] [Abstract][Full Text] [Related]
3. Brain glucose metabolism in Parkinson's disease.
Metter EJ; Kuhl DE; Riege WH
Adv Neurol; 1990; 53():135-9. PubMed ID: 2239454
[No Abstract] [Full Text] [Related]
4. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
Martin WR; Stoessl AJ; Adam MJ; Ammann W; Bergstrom M; Harrop R; Laihinen A; Rogers JG; Ruth TJ; Sayre CI
Adv Neurol; 1987; 45():95-8. PubMed ID: 3103398
[No Abstract] [Full Text] [Related]
5. Serial positron emission tomography with fludeoxyglucose F 18 in Creutzfeldt-Jakob disease.
Ogawa T; Inugami A; Fujita H; Hatazawa J; Shimosegawa E; Kanno I; Okudera T; Uemura K; Nagata K
AJNR Am J Neuroradiol; 1995 Apr; 16(4 Suppl):978-81. PubMed ID: 7611090
[TBL] [Abstract][Full Text] [Related]
6. Regional cerebral glucose metabolism and attention in adults with a history of childhood autism.
Siegel BV; Asarnow R; Tanguay P; Call JD; Abel L; Ho A; Lott I; Buchsbaum MS
J Neuropsychiatry Clin Neurosci; 1992; 4(4):406-14. PubMed ID: 1422167
[TBL] [Abstract][Full Text] [Related]
7. Asymmetry of basal ganglia glucose metabolism and dopa responsiveness in parkinsonism.
Dethy S; Van Blercom N; Damhaut P; Wikler D; Hildebrand J; Goldman S
Mov Disord; 1998 Mar; 13(2):275-80. PubMed ID: 9539341
[TBL] [Abstract][Full Text] [Related]
8. Cerebral metabolic dysfunction in AIDS: findings in a sample with and without dementia.
van Gorp WG; Mandelkern MA; Gee M; Hinkin CH; Stern CE; Paz DK; Dixon W; Evans G; Flynn F; Frederick CJ
J Neuropsychiatry Clin Neurosci; 1992; 4(3):280-7. PubMed ID: 1498579
[TBL] [Abstract][Full Text] [Related]
9. MR and positron emission tomography with fludeoxyglucose F 18 in gliomatosis cerebri.
Dexter MA; Parker GD; Besser M; Ell J; Fulham MJ
AJNR Am J Neuroradiol; 1995 Aug; 16(7):1507-10. PubMed ID: 7484643
[TBL] [Abstract][Full Text] [Related]
10. Metabolic topography of the hemiparkinsonism-hemiatrophy syndrome.
Przedborski S; Giladi N; Takikawa S; Ishikawa T; Dhawan V; Spetsieris P; Chaly T; Fahn S; Eidelberg D
Neurology; 1994 Sep; 44(9):1622-8. PubMed ID: 7936286
[TBL] [Abstract][Full Text] [Related]
11. [Functional significance of calcinosis of the basal ganglia via positron emission tomography].
Staffen W; Karbe H; Rudolf J; Herholz K; Diederich N; Heiss WD
Fortschr Neurol Psychiatr; 1994 Apr; 62(4):119-24. PubMed ID: 8206464
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomographic studies during serial word-reading by normal and dyslexic adults.
Gross-Glenn K; Duara R; Barker WW; Loewenstein D; Chang JY; Yoshii F; Apicella AM; Pascal S; Boothe T; Sevush S
J Clin Exp Neuropsychol; 1991 Jul; 13(4):531-44. PubMed ID: 1918284
[TBL] [Abstract][Full Text] [Related]
13. [Musical-verbal hallucinations and their correlation with electroencephalography and PET findings. Case report].
Erkwoh R; Ebel H; Kachel F; Reiche W; Ringelstein EB; Zimmermann J; Büll U; Sass H
Nervenarzt; 1992 Mar; 63(3):169-74. PubMed ID: 1579175
[TBL] [Abstract][Full Text] [Related]
14. The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.
Eidelberg D; Dhawan V; Moeller JR; Sidtis JJ; Ginos JZ; Strother SC; Cederbaum J; Greene P; Fahn S; Powers JM
J Neurol Neurosurg Psychiatry; 1991 Oct; 54(10):856-62. PubMed ID: 1744638
[TBL] [Abstract][Full Text] [Related]
15. Different cerebral metabolism between parkinsonian rigidity and hyperkinesia (DID, chorea, dystonia). A PET study.
Hirato M; Horikoshi S; Kawashima Y; Satake K; Shibazaki T; Ohye C
Adv Neurol; 1993; 60():511-4. PubMed ID: 8420180
[No Abstract] [Full Text] [Related]
16. Regional cerebral glucose metabolism in major depressive disorder.
Hurwitz TA; Clark C; Murphy E; Klonoff H; Martin WR; Pate BD
Can J Psychiatry; 1990 Nov; 35(8):684-8. PubMed ID: 2282619
[TBL] [Abstract][Full Text] [Related]
17. Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder.
Baxter LR; Schwartz JM; Mazziotta JC; Phelps ME; Pahl JJ; Guze BH; Fairbanks L
Am J Psychiatry; 1988 Dec; 145(12):1560-3. PubMed ID: 3264118
[TBL] [Abstract][Full Text] [Related]
18. Cerebral glucose metabolism in epilepsy patients associated with organic brain damage.
Otsuki T; Nakasato N; Kameyama M; Sato K; Jokura H; Seki K; Yoshimoto T
Jpn J Psychiatry Neurol; 1991 Jun; 45(2):404-6. PubMed ID: 1762230
[No Abstract] [Full Text] [Related]
19. Regional cerebral glucose metabolism in autopsy-confirmed Creutzfeldt-Jakob disease.
Matochik JA; Molchan SE; Zametkin AJ; Warden DL; Sunderland T; Cohen RM
Acta Neurol Scand; 1995 Feb; 91(2):153-7. PubMed ID: 7785428
[TBL] [Abstract][Full Text] [Related]
20. PET in relation to intracranial electrode evaluations.
Engel J; Henry TR; Risinger MW; Sutherling WW; Chugani HT
Epilepsy Res Suppl; 1992; 5():111-20. PubMed ID: 1418439
[No Abstract] [Full Text] [Related]
[Next] [New Search]
